SLS Analysis

SELLAS Life Sciences Group, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
5.31
Last session price
5.31
Price now
Currency: USD
Reporting currency: USD
ISIN: US81642T2096
INN:
.

SLS financial statements

* Numbers in thousands
Capitalization * 35 672
EV * 7 327
Number of shares * 6 718
EPS 0,00
Revenue * 2
Net income * -17
Operating profit * -17
Total liabilities * 18 088
Net debt * -33 652
Total assets * 38 839
Equity * 27 961
Cash and investments * 35 302
.

SLS valuation

P/E -2 128,79
P/B 1,28
P/S 18 774,80
E/P 0
P/FCF -3,42
.

SLS profitability

ROE 0%
ROA% 0%
ROIC% 0%